Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials
INTRODUCTION: Even though increased use of reliever medication, including short-acting beta agonists (SABA), provides an indirect measure of symptom worsening, there have been limited efforts to assess how different patterns of reliever use correlate with symptom control and future risk of exacerbations. Here, we evaluate the effect of individual baseline characteristics on reliever use in patients with moderate-severe asthma on regular maintenance therapy with fluticasone propionate (FP) or combination therapy with fluticasone propionate/salmeterol (FP/SAL) or budesonide/formoterol (BUD/FOR).... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2024 |
Verlag/Hrsg.: |
Springer Science and Business Media LLC
|
Schlagwörter: | Asthma symptom control / Drug-disease modelling / Exacerbation / ICS/LABA combination therapy / Inhaled corticosteroids / Reliever medication / Rescue medication / SABA / Short-acting beta agonists |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29245406 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://discovery.ucl.ac.uk/id/eprint/10186844/1/s12325-023-02774-w.pdf |